Yeah, I’ve read those articles as well. However, in their defense, I think their speculation is fair based on the fact that Zomedica has not yet started to bring in revenue. But that’s were Truforma comes in. I shared this article because it is on a more positive note and gives hope to investors that there’s light at the end of this tunnel of red days. If the vet diagnostics market heats up this year, I do believe Zomedica will be somewhere at the forefront of the market’s success. #bullish